Longevity now offers the Galleri multi-cancer early detection test. Now, we can screen for a signal shared by 50+ cancers, including fast-spreading, aggressive cancers that don’t show symptoms in early stages, such as pancreatic and ovarian.

The Galleri test screens your blood sample (two tubes of blood) for cell-free DNA and identifies whether it comes from healthy or cancer cells.

Get ahead of cancer when it's most treatable

Finding cancer early creates the best chance for successful treatment.   The Galleri® multi-cancer early detection test*— in a clinical study the test detected a signal shared by more than 50 types of cancer, including many not commonly screened for today.1,2   With a simple blood draw, the Galleri test can provide early detection insights that help you to be proactive about your health.   This is a revolutionary way to look for a signal associated with active cancer.

Who is Galleri test for?

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.